Induction of Response and Remission of Vedolizumab Monotherapy Vs Combination Therapy With Tacrolimus in Patients With Moderately to Severely Active Ulcerative Colitis
Phase of Trial: Phase III
Latest Information Update: 13 Jul 2017
At a glance
- Drugs Tacrolimus (Primary) ; Vedolizumab (Primary) ; Cotrimoxazole
- Indications Ulcerative colitis
- Focus Therapeutic Use
- Acronyms COVET
- 07 Jul 2017 Status changed from not yet recruiting to recruiting.
- 23 Mar 2017 Planned primary completion date changed from 1 Feb 2019 to 1 May 2019.
- 23 Mar 2017 Planned initiation date changed from 1 Feb 2017 to 1 May 2017.